Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
Conditions
- Cardiovascular Disease
- Peripheral Arterial Disease
- Diabetes Mellitus
- Coronary Heart Disease
Interventions
- DRUG: ER niacin/laropiprant
- DRUG: simvastatin
- DRUG: ezetimibe/simvastatin
Sponsor
University of Oxford
Collaborators